- Home
- ONMD vs ESLA Comparison
ONMD vs ESLA Comparison
Compare ONMD & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- ESLA
- Stock Information
- Founded
- ONMD 2006
- ESLA 2021
- Country
- ONMD United States
- ESLA United States
- Employees
- ONMD N/A
- ESLA N/A
- Industry
- ONMD
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONMD
- ESLA Health Care
- Exchange
- ONMD Nasdaq
- ESLA Nasdaq
- Market Cap
- ONMD 38.9M
- ESLA 35.9M
- IPO Year
- ONMD N/A
- ESLA N/A
- Fundamental
- Price
- ONMD $0.89
- ESLA $1.15
- Analyst Decision
- ONMD
- ESLA Strong Buy
- Analyst Count
- ONMD 0
- ESLA 1
- Target Price
- ONMD N/A
- ESLA $16.00
- AVG Volume (30 Days)
- ONMD 1.6M
- ESLA 34.5K
- Earning Date
- ONMD 08-13-2025
- ESLA 08-12-2025
- Dividend Yield
- ONMD N/A
- ESLA N/A
- EPS Growth
- ONMD N/A
- ESLA N/A
- EPS
- ONMD N/A
- ESLA N/A
- Revenue
- ONMD $459,000.00
- ESLA N/A
- Revenue This Year
- ONMD N/A
- ESLA N/A
- Revenue Next Year
- ONMD N/A
- ESLA N/A
- P/E Ratio
- ONMD N/A
- ESLA N/A
- Revenue Growth
- ONMD N/A
- ESLA N/A
- 52 Week Low
- ONMD $0.30
- ESLA $0.63
- 52 Week High
- ONMD $1.56
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- ONMD 59.80
- ESLA 66.88
- Support Level
- ONMD $0.82
- ESLA $1.04
- Resistance Level
- ONMD $0.92
- ESLA $1.23
- Average True Range (ATR)
- ONMD 0.07
- ESLA 0.07
- MACD
- ONMD -0.01
- ESLA 0.01
- Stochastic Oscillator
- ONMD 74.43
- ESLA 64.00
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.